Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity

Journal Article · · Virology Journal
 [1];  [2];  [2];  [2];  [2];  [2];  [3];  [3];  [4];  [4];  [2];  [2];  [2];  [2];  [2]
  1. Univ. of Maryland Baltimore County (UMBC), Baltimore, MD (United States). School of Medicine. Inst. of Human Virology; DOE/OSTI
  2. Univ. of Maryland Baltimore County (UMBC), Baltimore, MD (United States). School of Medicine. Inst. of Human Virology
  3. Virginia Polytechnic Inst. and State Univ. (Virginia Tech), Blacksburg, VA (United States). Virginia Bioinformatics Inst.
  4. Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States). Global Security Directorate
Background: Lassa hemorrhagic fever (LHF) is a rodent-borne viral disease that can be fatal for human beings. In this study, an attenuated Lassa vaccine candidate, ML29, was tested in SIV-infected rhesus macaques for its ability to elicit immune responses without instigating signs pathognomonic for arenavirus disease. ML29 is a reassortant between Lassa and Mopeia viruses that causes a transient infection in non-human primates and confers sterilizing protection from lethal Lassa viral challenge. However, since the LHF endemic area of West Africa also has high HIV seroprevalence, it is important to determine whether vaccination could be safe in the context of HIV infection. Results: SIV-infected and uninfected rhesus macaques were vaccinated with the ML29 virus and monitored for specific humoral and cellular immune responses, as well as for classical and non-classical signs of arenavirus disease. Classical disease signs included viremia, rash, respiratory distress, malaise, high liver enzyme levels, and virus invasion of the central nervous system. Non-classical signs, derived from profiling the blood transcriptome of virulent and non-virulent arenavirus infections, included increased expression of interferon-stimulated genes (ISG) and decreased expression of COX2, IL-1β, coagulation intermediates and nuclear receptors needed for stress signaling. All vaccinated monkeys showed ML29-specific antibody responses and ML29-specific cellmediated immunity. Conclusion: SIV-infected and uninfected rhesus macaques responded similarly to ML29 vaccination, and none developed chronic arenavirus infection. Importantly, none of the macaques developed signs, classical or nonclassical, of arenavirus disease.
Research Organization:
Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
Sponsoring Organization:
National Institutes of Health (NIH); USDOD; USDOE Laboratory Directed Research and Development (LDRD) Program; USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division
Grant/Contract Number:
AC52-07NA27344
OSTI ID:
1626615
Journal Information:
Virology Journal, Journal Name: Virology Journal Journal Issue: 1 Vol. 10; ISSN 1743-422X
Publisher:
BioMed CentralCopyright Statement
Country of Publication:
United States
Language:
English

References (67)

Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever journal January 2004
Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus journal April 2002
Experimental Studies of Arenaviral Hemorrhagic Fevers book January 1987
Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses journal December 2006
Generation of reassortants between African arenaviruses journal June 1992
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates journal September 2008
Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model journal February 2012
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins journal February 2006
Protection of Rhesus Monkeys from Lassa Virus by Immunisation with Closely Related Arenavirus journal October 1979
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients journal April 1999
From The Cover: The host response to smallpox: Analysis of the gene expression program in peripheral blood cells in a nonhuman primate model journal October 2004
Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. journal January 1989
Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques. journal June 1996
Smallpox Vaccine Does Not Protect Macaques with AIDS from a Lethal Monkeypox Virus Challenge journal February 2005
Presence of Mopeia Virus, an African Arenavirus, Related to Biotope and Individual Rodent Host Characteristics: Implications for Virus Transmission journal August 2011
Clinical Virology of Lassa Fever in Hospitalized Patients journal March 1987
Separation of Peripheral Leukocytes by Ficoll Density Gradient Centrifugation journal January 1971
Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression. journal October 1998
Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections journal March 2007
Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma journal May 1996
Reference Values of CD4 T Lymphocytes in Human Immunodeficiency Virus-Negative Adult Nigerians journal April 2005
Early Blood Profiles of Virus Infection in a Monkey Model for Lassa Fever journal May 2007
Identification of Differentially Activated Cell-Signaling Networks Associated with Pichinde Virus Pathogenesis by Using Systems Kinomics journal December 2006
New Adenovirus Species Found in a Patient Presenting with Gastroenteritis journal June 2007
Lassa Virus Infection in Experimentally Infected Marmosets: Liver Pathology and Immunophenotypic Alterations in Target Tissues journal April 2007
Selective amplification of simian immunodeficiency virus genotypes after intrarectal inoculation of rhesus monkeys journal November 1994
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection journal December 1994
A Live Attenuated Vaccine for Lassa Fever Made by Reassortment of Lassa and Mopeia Viruses journal November 2005
Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice journal September 1995
A microbial detection array (MDA) for viral and bacterial detection journal January 2010
Gene expression in primate liver during viral hemorrhagic fever journal January 2009
Development of a New Vaccine for the Prevention of Lassa Fever journal June 2005
Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates journal November 2008
T Cell-Dependence of Lassa Fever Pathogenesis journal March 2010
Circulating natural killer and γδ T cells decrease soon after infection of rhesus macaques with lymphocytic choriomeningitis virus journal July 2009
Lassa Virus Hepatitis: a Study of Fatal Lassa Fever in Humans journal March 1986
Lassa Fever book January 2002
Pathophysiology and Treatment of Lassa Fever book January 1987
Epidemiology and Control of Lassa Fever book January 1987
Generation of reassortants between African arenaviruses journal June 1992
Protection of Rhesus Monkeys from Lassa Virus by Immunisation with Closely Related Arenavirus journal October 1979
Lassa Fever book May 2014
A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity journal May 2007
Lassa Fever book January 1993
Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice journal August 2011
Attenuated and Lethal Variants of Pichindé Virus Induce Differential Patterns of NF-κB Activation Suggesting a Potential Target for Novel Therapeutics journal December 2009
Lassa fever journal January 2016
Early Blood Profiles of Virus Infection in a Monkey Model for Lassa Fever journal May 2007
Early and Strong Immune Responses Are Associated with Control of Viral Replication and Recovery in Lassa Virus-Infected Cynomolgus Monkeys journal March 2009
Identification of Differentially Activated Cell-Signaling Networks Associated with Pichinde Virus Pathogenesis by Using Systems Kinomics journal December 2006
New Adenovirus Species Found in a Patient Presenting with Gastroenteritis journal June 2007
Lassa Virus Infection in Experimentally Infected Marmosets: Liver Pathology and Immunophenotypic Alterations in Target Tissues journal April 2007
Arenavirus-Mediated Liver Pathology: Acute Lymphocytic Choriomeningitis Virus Infection of Rhesus Macaques Is Characterized by High-Level Interleukin-6 Expression and Hepatocyte Proliferation journal February 2003
A Live Attenuated Vaccine for Lassa Fever Made by Reassortment of Lassa and Mopeia Viruses journal November 2005
Lassa fever journal July 2017
Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus journal August 2009
Identification and utilization of inter-species conserved (ISC) probesets on Affymetrix human GeneChip® platforms for the optimization of the assessment of expression patterns in non human primate (NHP) samples journal October 2004
Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase journal July 2004
Gene expression in primate liver during viral hemorrhagic fever journal January 2009
Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: Case Report journal January 2011
Isolation and Characterization of Adenoviruses Persistently Shed from the Gastrointestinal Tract of Non-Human Primates journal July 2009
Circulating natural killer and γδ T cells decrease soon after infection of rhesus macaques with lymphocytic choriomeningitis virus journal July 2009
Lassa fever book January 1999
Epidemiology and Control of Lassa fever journal May 2018
Advanced Vaccine Candidates for Lassa Fever journal October 2012
T cell-dependence of Lassa fever pathogenesis text January 2010
A microbial detection array (MDA) for viral and bacterial detection collection January 2021

Cited By (13)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens journal October 2017
Lassa virus diversity and feasibility for universal prophylactic vaccine journal January 2019
The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model journal July 2018
A Single Dose of Modified Vaccinia Ankara Expressing Lassa Virus-like Particles Protects Mice from Lethal Intra-cerebral Virus Challenge journal August 2019
Mammarenaviral Infection Is Dependent on Directional Exposure to and Release from Polarized Intestinal Epithelia journal February 2018
Modulation of SIV and HIV DNA Vaccine Immunity by Fas-FasL Signaling journal March 2015
T-Cell Response to Viral Hemorrhagic Fevers journal January 2019
General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines journal December 2015
A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins journal June 2018
The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses journal March 2016
A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene journal February 2020
Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors journal March 2019
VaxCelerate II: Rapid development of a self-assembling vaccine for Lassa fever journal October 2014

Similar Records

Nef gene evolution from a single transmitted strain in acute SIV infection
Journal Article · Sun Jun 07 20:00:00 EDT 2009 · Retrovirology · OSTI ID:1626605

Modeling the Effects of Morphine-Altered Virus Specific Antibody Responses on HIV/SIV Dynamics
Journal Article · Sun Mar 31 20:00:00 EDT 2019 · Scientific Reports · OSTI ID:1619505